| answer text |
<p>The UK Government acknowledges the importance of Human papillomavirus (HPV) vaccinations
in preventing deaths from cervical cancer. As the largest donor to Gavi's core mission
contributing £1.65 billion to the Global Vaccine Alliance's (Gavi) 2021-2025 strategic
period, the UK supports Gavi's efforts to accelerate the introduction, access and
coverage of the vaccine in low- or middle-income countries (LMICs) with the aim of
immunising 86 million more girls by 2025. Alongside our Gavi investment, we are committed
to working with countries and with the wider international community to focus efforts
on building stronger primary health systems for the future as a core part of increasing
access to immunisation services around the world.</p>
|
 |
